abzu.ai: Revolutionizing RNA Therapeutics with Explainable AI

abzu.ai is a pioneering AI-driven pharmaceutical research and development company specializing in the design of RNA therapeutics, including siRNAs, anti-miRs, and ASOs. Leveraging its proprietary, ISO 27001-certified QLattice® explainable AI platform, abzu.ai delivers transparent, trustworthy, and high-accuracy predictive modeling for drug properties such as activity, stability, toxicity, and off-target effects. The company offers a seamless one-stop solution—from target identification to in vitro validation—using a data-rich, in-house pipeline enhanced by custom models and real-time LNP design tools. With a strong commitment to ethical AI, scientific rigor, and innovation, abzu.ai has been recognized by Gartner® as a "Cool Vendor" and has published research in top-tier journals, including Nature Portfolio and Biomarkers. Its mission is to increase the success rate of in-silico drug design, enabling clinical candidates to reach the clinic twice as often and at half the cost.

Key Features:

• QLattice® Explainable AI Platform: Proprietary, patented technology for symbolic regression that generates interpretable mathematical models.
• AI-Powered RNA Therapeutics Design: Specialized in siRNA, anti-miR, and ASO design with high accuracy and safety.
• Predictive Modeling for Drug Properties: Forecasts activity, cross-reactivity, off-target potential, stability, and physicochemical traits.
• Real-Time LNP Designer: Predicts apparent pKa values for lipid nanoparticles to optimize delivery.
• In-House Data & Research: Develops and curates high-quality proprietary data to train and validate AI models.
• Custom AI Model Development: Featurizes client-specific screening data to build tailored models.
• Fast Oligo Sequence Aligner: Enables rapid computation in hours rather than days.
• Ethical & Transparent AI Use: Emphasizes explainability, autonomy, and compliance with GDPR and responsible AI principles.
• Scientific Collaboration & Publications: Active in research partnerships with academic and industry leaders; over 190 publications citing QLattice®.
• Integrated Workflow Solution: Streamlines the entire drug discovery pipeline from concept to validated candidates.
• Training & Onboarding Support: Offers expert-led sessions for scientists and researchers.
• Cookie-Less Privacy Policy: Ensures user privacy with no tracking or marketing cookies.
• Global Expert Team: 14 multidisciplinary Abzoids from 8 nationalities, including PhDs in bioinformatics and computational biophysics.

Pricing: abzu.ai offers a subscription-based model for its QLattice® platform and pharma R&D services, with tailored pricing for enterprise and research partnerships.

Conclusion: abzu.ai stands at the forefront of responsible, explainable AI in drug discovery, delivering powerful, transparent solutions that accelerate RNA therapeutic development with proven improvements in safety and efficiency—ideal for forward-thinking pharma and research teams.